Forging alliances to tackle neglected tropical diseases

For those working to eliminate neglected tropical diseases, or NTDs, the U.S. foreign aid freeze that began in January 2025 ushered in a new set of challenges. But pharmaceutical companies that have displayed a long-term commitment to the elimination of NTDs remain steadfast in their mission to find solutions and help millions of people around the world escape the neglect.

Here, Bayer Pharmaceuticals’ Chief Health Equity Officer Claus Runge explains how the company’s commitments have driven progress and why strong partnerships are key.

Visit Escape the Neglect (https://pages.devex.com/escapetheneglect.html) — a series exploring the extraordinary progress that countries are making in eliminating neglected tropical diseases, or NTDs, and showcasing promising opportunities to build on recent wins.

For more international development news, visit: http://www.devex.com

Subscribe to the Devex YouTube channel: http://www.youtube.com/subscription_center?add_user=wwwdevexcom

Видео Forging alliances to tackle neglected tropical diseases канала Devex